Pathogen Reduction System Market 2028 By Product Type, Type, Application, End User, and Geography | The Insight Partners

report image

Pathogen Reduction System Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Semi-Automated Pathogen Reduction System, Fully-Automated Pathogen Reduction System); Type (Plasma Pathogen Reduction, Whole blood Pathogen Reduction, Platelets Pathogen Reduction); Application (Viruses , Bacteria, Parasites, White Blood Cells); End User (Hospitals , Ambulatory Surgical Center , Research Centers, Blood Banks, Others), and Geography

Report Code: TIPRE00015233 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming


Pathogen reduction systems are widely used to inactivate viruses and bacteria that may contaminate blood products. The pathogen reduction systems work on the principle of exposing the plasma to the ultraviolet rays in the presence of photosensitizer to act as a pathogen inactivator. The pathogen reduction systems are manufactured to withstand infectious pathogens of different genera. The inactivation strength of the photosensitizer varies from product to product. Primarily the products are for blood infection disease applications. The Pathogen Reduction Systems is an advanced product offering in the management of the blood transfusion and pathogen inactivation. Current pathogen reduction technologies in practice utilize nucleic acid-targeting methodology through ultraviolet light for destroying pathogens such as viruses, bacteria, protozoa, and others.


The increase in demand for plasma proteins, rising investment in innovation, and continuously increasing prevalence of infectious diseases will spur the growth of the market. Additionally, growing demand for blood components and blood in various surgeries and interventions coupled with high prevalence of the infectious disease will boost the market growth to significant extent over the forecast period. However, constantly rising product launch and product penetration and fair reimbursement issues may restrain the growth of the market in the forecasted period.


The "Global Pathogen Reduction Systems Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of pathogen reduction systems market with detailed market segmentation by type, product type, application, end-users and geography. The global pathogen reduction systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading pathogen reduction systems market players and offers key trends and opportunities in the market.


The global pathogen reduction systems market is segmented on the type, product type, application, and end-users. Based on type, the global pathogen reduction systems market is segmented plasma pathogen reduction, platelets pathogen reduction, and whole blood pathogen reduction. Based on product type, the global pathogen reduction systems market is segmented semi-automated pathogen reduction system, and fully-automated pathogen reduction system. Based on application, the global pathogen reduction systems market is segmented into viruses, bacteria, parasites, and white blood cells. Based on end user, the global pathogen reduction systems market is segmented into hospitals, blood banks, ambulatory surgical center, research centers, and others.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pathogen reduction systems market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pathogen reduction systems market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pathogen reduction systems market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Pathogen reduction systems market in these regions.

Get more information on this report :


The reports cover key developments in the pathogen reduction systems market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pathogen reduction systems market are anticipated to lucrative growth opportunities in the future with the rising demand for pathogen reduction systems market in the global market. Below mentioned is the list of few companies engaged in the pathogen reduction systems market.

The report also includes the profiles of key pathogen reduction systems market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Cerus Corporation
  •   Macopharma
  •   Octapharma
  •   AngioDynamics, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

2. Cerus Corporation
3. Macopharma
4. Octapharma
5. AngioDynamics, Inc.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount